Starpharma Holdings Price to Book Ratio 2011-2021 | SPHRY
Historical price to book ratio values for Starpharma Holdings (SPHRY) over the last 10 years. The current price to book ratio for Starpharma Holdings as of July 01, 2022 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|Starpharma Holdings Price/Book Ratio Historical Data
||Book Value per Share
||Price to Book Ratio
||Medical - Biomedical and Genetics
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.